Logo image of CRBG

COREBRIDGE FINANCIAL INC (CRBG) Stock Fundamental Analysis

NYSE:CRBG - New York Stock Exchange, Inc. - US21871X1090 - Common Stock - Currency: USD

32.7  -0.79 (-2.36%)

After market: 32.8 +0.1 (+0.31%)

Fundamental Rating

5

Taking everything into account, CRBG scores 5 out of 10 in our fundamental rating. CRBG was compared to 101 industry peers in the Financial Services industry. CRBG has a medium profitability rating, but doesn't score so well on its financial health evaluation. CRBG scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CRBG was profitable.
In the past year CRBG had a positive cash flow from operations.
In the past 5 years CRBG has always been profitable.
In the past 5 years CRBG always reported a positive cash flow from operatings.
CRBG Yearly Net Income VS EBIT VS OCF VS FCFCRBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

CRBG has a worse Return On Assets (0.57%) than 65.35% of its industry peers.
The Return On Equity of CRBG (19.46%) is better than 82.18% of its industry peers.
CRBG has a worse Return On Invested Capital (0.64%) than 63.37% of its industry peers.
CRBG had an Average Return On Invested Capital over the past 3 years of 1.08%. This is significantly below the industry average of 7.75%.
Industry RankSector Rank
ROA 0.57%
ROE 19.46%
ROIC 0.64%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
CRBG Yearly ROA, ROE, ROICCRBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

The Profit Margin of CRBG (12.50%) is comparable to the rest of the industry.
CRBG's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 17.77%, CRBG is in the better half of the industry, outperforming 60.40% of the companies in the same industry.
In the last couple of years the Operating Margin of CRBG has grown nicely.
Industry RankSector Rank
OM 17.77%
PM (TTM) 12.5%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBG Yearly Profit, Operating, Gross MarginsCRBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRBG is destroying value.
Compared to 1 year ago, CRBG has less shares outstanding
CRBG has less shares outstanding than it did 5 years ago.
CRBG has a worse debt/assets ratio than last year.
CRBG Yearly Shares OutstandingCRBG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBG Yearly Total Debt VS Total AssetsCRBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

The Debt to FCF ratio of CRBG is 5.76, which is a neutral value as it means it would take CRBG, 5.76 years of fcf income to pay off all of its debts.
CRBG has a better Debt to FCF ratio (5.76) than 61.39% of its industry peers.
CRBG has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
CRBG has a Debt to Equity ratio (1.08) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 5.76
Altman-Z N/A
ROIC/WACC0.06
WACC11.64%
CRBG Yearly LT Debt VS Equity VS FCFCRBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBG Yearly Current Assets VS Current LiabilitesCRBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.05% over the past year.
Measured over the past years, CRBG shows a very strong growth in Earnings Per Share. The EPS has been growing by 115.54% on average per year.
CRBG shows a decrease in Revenue. In the last year, the revenue decreased by -1.13%.
The Revenue has been growing by 8.01% on average over the past years. This is quite good.
EPS 1Y (TTM)18.05%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%18.27%
Revenue 1Y (TTM)-1.13%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%-15.31%

3.2 Future

Based on estimates for the next years, CRBG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.21% on average per year.
Based on estimates for the next years, CRBG will show a small growth in Revenue. The Revenue will grow by 6.54% on average per year.
EPS Next Y13.59%
EPS Next 2Y14.4%
EPS Next 3Y14.21%
EPS Next 5YN/A
Revenue Next Year8.29%
Revenue Next 2Y6.82%
Revenue Next 3Y6.54%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRBG Yearly Revenue VS EstimatesCRBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B 25B
CRBG Yearly EPS VS EstimatesCRBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.76, the valuation of CRBG can be described as very cheap.
Based on the Price/Earnings ratio, CRBG is valued cheaper than 87.13% of the companies in the same industry.
CRBG is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 5.95, which indicates a rather cheap valuation of CRBG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBG indicates a rather cheap valuation: CRBG is cheaper than 90.10% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CRBG to the average of the S&P500 Index (22.68), we can say CRBG is valued rather cheaply.
Industry RankSector Rank
PE 6.76
Fwd PE 5.95
CRBG Price Earnings VS Forward Price EarningsCRBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

76.24% of the companies in the same industry are more expensive than CRBG, based on the Enterprise Value to EBITDA ratio.
CRBG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRBG is cheaper than 78.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.5
EV/EBITDA 9.99
CRBG Per share dataCRBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CRBG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRBG's earnings are expected to grow with 14.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)0.06
EPS Next 2Y14.4%
EPS Next 3Y14.21%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.87%, CRBG has a reasonable but not impressive dividend return.
CRBG's Dividend Yield is a higher than the industry average which is at 3.84.
CRBG's Dividend Yield is a higher than the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 2.87%

5.2 History

CRBG has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CRBG Yearly Dividends per shareCRBG Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

24.39% of the earnings are spent on dividend by CRBG. This is a low number and sustainable payout ratio.
DP24.39%
EPS Next 2Y14.4%
EPS Next 3Y14.21%
CRBG Yearly Income VS Free CF VS DividendCRBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBG Dividend Payout.CRBG Dividend Payout, showing the Payout Ratio.CRBG Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC

NYSE:CRBG (2/21/2025, 7:12:27 PM)

After market: 32.8 +0.1 (+0.31%)

32.7

-0.79 (-2.36%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-01 2025-05-01/bmo
Inst Owners101.26%
Inst Owner Change-1.74%
Ins Owners0.25%
Ins Owner Change-62.31%
Market Cap22.59B
Analysts79.09
Price Target39 (19.27%)
Short Float %1.46%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield 2.87%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP24.39%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-17 2025-03-17 (0.24)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.84%
Min EPS beat(2)-0.2%
Max EPS beat(2)15.87%
EPS beat(4)3
Avg EPS beat(4)4.63%
Min EPS beat(4)-0.2%
Max EPS beat(4)15.87%
EPS beat(8)6
Avg EPS beat(8)5.6%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.15%
Min Revenue beat(2)-21.6%
Max Revenue beat(2)-14.69%
Revenue beat(4)1
Avg Revenue beat(4)-14.95%
Min Revenue beat(4)-28.97%
Max Revenue beat(4)5.48%
Revenue beat(8)5
Avg Revenue beat(8)1.26%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.45%
PT rev (3m)12.5%
EPS NQ rev (1m)-3.89%
EPS NQ rev (3m)-4.67%
EPS NY rev (1m)-0.86%
EPS NY rev (3m)0.95%
Revenue NQ rev (1m)-5.45%
Revenue NQ rev (3m)-3.4%
Revenue NY rev (1m)-2.46%
Revenue NY rev (3m)-4.85%
Valuation
Industry RankSector Rank
PE 6.76
Fwd PE 5.95
P/S 1.27
P/FCF 10.5
P/OCF 10.5
P/B 1.97
P/tB 1.97
EV/EBITDA 9.99
EPS(TTM)4.84
EY14.8%
EPS(NY)5.5
Fwd EY16.81%
FCF(TTM)3.11
FCFY9.52%
OCF(TTM)3.11
OCFY9.52%
SpS25.83
BVpS16.59
TBVpS16.59
PEG (NY)0.5
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 19.46%
ROCE 0.82%
ROIC 0.64%
ROICexc 0.64%
ROICexgc 0.95%
OM 17.77%
PM (TTM) 12.5%
GM N/A
FCFM 12.05%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
ROICexc(3y)1.09%
ROICexc(5y)0.99%
ROICexgc(3y)1.62%
ROICexgc(5y)1.5%
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexcg growth 3Y-24.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y-23.75%
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 5.76
Debt/EBITDA 3.68
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.9
Cash Conversion 63.92%
Profit Quality 96.46%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC11.64%
ROIC/WACC0.06
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)18.05%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%18.27%
EPS Next Y13.59%
EPS Next 2Y14.4%
EPS Next 3Y14.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.13%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%-15.31%
Revenue Next Year8.29%
Revenue Next 2Y6.82%
Revenue Next 3Y6.54%
Revenue Next 5YN/A
EBIT growth 1Y232.5%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.87%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-35.87%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%